Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 8/20 | 0.60 |
| ▸ | NAALAD2 | Q9Y3Q0 | 3/20 | 0.60 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.60 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.57 |
| ▸ | GABRP | O00591 | 2/20 | 0.50 |
| ▸ | GABRD | O14764 | 2/20 | 0.50 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.50 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.50 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.50 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.50 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.50 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.50 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.50 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.50 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.50 |
| ▸ | GABRE | P78334 | 2/20 | 0.50 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.50 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.50 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.50 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11188341 | 1.00 | FOLH1 (0.60) | FOLH1NAALAD2RIMKLANOD1GABRP | |
| SCHEMBL7937311 | 1.00 | FOLH1 (0.60) | FOLH1NAALAD2RIMKLANOD1GABRP | |
| SCHEMBL29959406 | 1.00 | FOLH1 (0.60) | FOLH1NAALAD2RIMKLANOD1GABRP | |
| SCHEMBL2490631 | 1.00 | FOLH1 (0.60) | FOLH1NAALAD2RIMKLANOD1GABRP | |
| SCHEMBL1270356 | 1.00 | FOLH1 (0.60) | FOLH1NAALAD2RIMKLANOD1GABRP | |
| SCHEMBL23044064 | 1.00 | FOLH1 (0.60) | FOLH1NAALAD2RIMKLANOD1GABRP | |
| Hydrochloric Acid SCHEMBL8728073 | 0.98 | FOLH1 (0.58) | FOLH1NAALAD2RIMKLANOD1GABRP | |
| Hydrochloric Acid SCHEMBL11283847 | 0.98 | FOLH1 (0.58) | FOLH1NAALAD2RIMKLANOD1GABRP | |
| Hydrochloric Acid SCHEMBL8728071 | 0.98 | FOLH1 (0.58) | FOLH1NAALAD2RIMKLANOD1GABRP | |
| SCHEMBL28727840 | 0.96 | FOLH1 (0.56) | FOLH1NAALAD2RIMKLANOD1GABRP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250242064-A1 | CXCR4-TARGETING COMPOUNDS, AND METHODS OF MAKING AND USING THE SAME | ALPHA-9 ONCOLOGY INC. (CA) | 2025-07-31 | — | — | US | claimed |
| EP-4511384-A1 | CXCR4-TARGETING COMPOUNDS, AND METHODS OF MAKING AND USING THE SAME | Provincial Health Services Authority (CA) | 2025-02-26 | — | — | EP | claimed |
| WO-2023201435-A1 | CXCR4-TARGETING COMPOUNDS, AND METHODS OF MAKING AND USING THE SAME | PROVINCIAL HEALTH SERVICES AUTHORITY (CA) | 2023-10-26 | — | — | WO | claimed |
| US-12616761-B2 | CXCR4-targeting compounds | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2026-05-05 | — | — | US | disclosed |
| US-20250242064-A1 | CXCR4-TARGETING COMPOUNDS, AND METHODS OF MAKING AND USING THE SAME | ALPHA-9 ONCOLOGY INC. (CA) | 2025-07-31 | — | — | US | disclosed |
| CN-110312533-B | Prodrugs of cytotoxic active agents having enzymatically cleavable groups | 拜耳公司 | 2023-11-03 | — | — | CN | disclosed |
| CN-116457028-A | Novel CXCR4 targeting compounds | 省卫生服务机构 | 2023-07-18 | — | — | CN | disclosed |
| CN-116327974-A | Antibody-drug-conjugates (ADCs) with enzymatically cleavable groups | 拜耳制药股份公司 | 2023-06-27 | — | — | CN | disclosed |
| CN-110312533-A | Prodrugs of cytotoxic active agents having an enzymatically cleavable group | 拜耳公司 | 2019-10-08 | — | — | CN | disclosed |
| CN-107921146-A | Spindle drives the antibody drug conjugate (ADC) of albumen (KSP) inhibitor and the antibody of anti-CD123 | 拜耳医药股份有限公司 | 2018-04-17 | — | — | CN | disclosed |
| WO-2001070937-A1 | A NEW THERMOSTABLE D-STEREOSPECIFIC DIPEPTIDASE FROM BREVIBACILLUS BOSTELENSIS BCS-1 AND ITS USE AS A BIOCATALYST FOR THE SYNTHESIS OF PEPTIDES CONTAINING D-AMINO ACIDS | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2001-09-27 | — | — | WO | disclosed |
| US-4421765-A | ANTIINFLAMMATORY AGENTS | CIBA-GEIGY CORPORATION (US) | 1983-12-20 | — | — | US | disclosed |
| US-4420490-A | ANTIINFLAMMATORY | CIBA-GEIGY CORPORATION (US) | 1983-12-13 | — | — | US | disclosed |
| US-4346105-A | ANTIINFLAMMATORY AGENTS | CIBA-GEIGY CORPORATION (US) | 1982-08-24 | — | — | US | disclosed |
| US-4346104-A | ANTIINFLAMMATORY | CIBA-GEIGY CORPORATION (US) | 1982-08-24 | — | — | US | disclosed |
| US-4322436-A | ANTIINFLAMMATORY AGENTS | CIBA-GEIGY CORPORATION (US) | 1982-03-30 | — | — | US | disclosed |
| US-4250192-A | ANTIINFLAMMATORY AGENTS | CIBA-GEIGY CORPORATION (US) | 1981-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250242064-A1 | CXCR4-TARGETING COMPOUNDS, AND METHODS OF MAKING AND USING THE SAME | CXCR4, CXCL12, ACKR3 | FOLH1 497/4885NAALAD2 2878/4885RIMKLA 3283/4885 |
| US-12616761-B2 | CXCR4-targeting compounds | CXCR4, CXCR2, CXCR3 | FOLH1 756/4885NAALAD2 1266/4885RIMKLA 1914/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.